![David Rodman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Rodman
Technik-/Wissenschafts-/F&E-Leiter bei
MINERALYS THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
David M.
Rodman is currently a Member-Editorial Board at American Thoracic Society, Inc. and Chief Medical Officer at Mineralys Therapeutics, Inc. since 2021.
Former roles include Vice President-Clinical Development at Vertex Pharmaceuticals, Inc. from 2011 to 2014; Executive Vice President-Research & Development at miRagen Therapeutics, Inc.; Professor at The University of Colorado; Head-Respiratory Translational Medicine at Novartis Institutes for Biomedical Research, Inc.; Chief Medical Officer & Executive VP-Discovery at Nivalis Therapeutics, Inc. from 2016 to 2017; and Executive Vice President-Research & Development at ProQR Therapeutics NV.
Education includes a doctorate from the University of Pennsylvania in 1980 and an undergraduate degree from Haverford College in 1976.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 57’095 ( 0.08% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von David Rodman
| Unternehmen | Position | Beginn |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
American Thoracic Society, Inc.
 American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von David Rodman
| Unternehmen | Position | Ende |
|---|---|---|
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Technik-/Wissenschafts-/F&E-Leiter | 15.01.2017 |
| VERTEX PHARMACEUTICALS INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2014 |
| PROQR THERAPEUTICS N.V. | Technik-/Wissenschafts-/F&E-Leiter | - |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
Ausbildung von David Rodman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
miRagen Therapeutics, Inc. /Old/
 miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haverford College
 Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Commercial Services |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Mineralys Therapeutics, Inc.
 Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
